Price movement over the last 24 hours
ARK Genomic Revolution ETF vs iShares Global Clean Energy ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while iShares Global Clean Energy ETF trades at $19. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | ICLN | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $23.75 |
52-Week Low | $23.09 | $13.37 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ICLN trades at $19.25, down 0.41% with a bearish technical signal from moving averages. The ETF shows strong 2026 performance with clean energy sector momentum driven by AI demand and high oil prices. Recent news highlights policy risks from US permit delays affecting $121 billion in renewable investments, while China's 2030 EV targets provide long-term growth catalysts. The fund offers global diversification across 105 clean energy holdings.
Outlook remains cautiously optimistic despite near-term policy headwinds. The structural shift toward clean energy infrastructure and growing global investment support long-term growth potential. Key risks include regulatory uncertainty and competitive pressure from traditional energy ETFs offering higher yields. Current levels may present accumulation opportunities for patient investors.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →